Musculoskeletal Diseases  >>  methylprednisolone acetate  >>  Phase 3
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
methylprednisolone acetate / Generic mfg.
NCT00131326: A Study of the Safety and Efficacy of Synvisc and Depo-Medrol in Patients With Osteoarthritis of the Hip

Completed
3
US
Synvisc (hylan G-F 20)
Genzyme, a Sanofi Company
Osteoarthritis, Hip, Musculoskeletal Diseases
 
04/06
NCT03327272: Impact of Local Steroid Application in Extreme Lateral Lumbar Interbody Fusion

Withdrawn
3
0
US
Methylprednisolone, Depomedrol, Saline
Rush University Medical Center
Stenosis, Herniated Nucleus Pulposus, Degenerative Disc Disease, Spondylosis, Myelopathy, Radiculopathy, Myeloradiculopathy
07/20
07/20
NCT05058287: Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression

Recruiting
3
150
US
Depo-Medrol 40Mg/Ml Suspension for Injection, Placebo
Hospital for Special Surgery, New York
Opioid Use, Lumbar Spinal Stenosis, Pain, Postoperative, Pain, Back
12/24
12/24
NCT01957631: Comparing Steroid Injections and Platelet Rich Plasma Injections in the Treatment of Plantar Fasciitis

Withdrawn
2/3
0
RoW
Corticosteroid injection (Bupivacaine and Depo Medrol), Bupivacaine, Depo Medrol, Platelet rich plasma injection
King Hamad University Hospital, Bahrain
Plantar Fasciitis
06/19
09/19

Download Options